Literature DB >> 7468766

Comparison of the chemotactic responsiveness of two fibrosarcoma subpopulations of differing malignancy.

F W Orr, J Varani, J Delikatny, N Jain, P A Ward.   

Abstract

There are several points of similarity between the processes of cancer metastasis and inflammation. In both, cells circulate in the vasculature, arrest, and cross vessel walls, thereby entering the extravascular tissues. In vitro, leukocytes and some, but not all, tumor cells exhibit chemotaxis. Since the chemotactic response of leukocytes effect their transvascular migration, we propose that chemotactic responsiveness contributes to the ability of circulating tumor cells to localize in extravascular tissues. This study was done to seek a relationship between chemotactic responsiveness of tumor cells and their behavior in vivo. Two subpopulations of cells were isolated from a methylcholanthrene-induced fibrosarcoma. The two cell lines were compared with regard to their biologic behavior in vivo and their chemotactic responsiveness in vitro. In vivo one subpopulation was highly malignant. An injection of 2.0 x 10(5) cells into the footpad of syngeneic mice led to the development of primary tumors in 87% of the animals and lung metastases in 61% of the animals with primary tumors. This line demonstrated chemotaxis to a factor that behaved similarly in gel filtration and showed immunologic reactivity similar to that of a previously described tumor cell chemotactic factor derived from the fifth component of complement. In contrast, an injection of the same number of cells from the second subpopulation of fibrosarcoma cells led to the development of primary tumors in only 12% of syngeneic mice, and lung metastases did not occur. Neither this subpopulation nor normal embryonic fibroblasts demonstrated chemotactic responsiveness. We postulate that the ability of tumor cells to respond to specific chemotactic stimuli may be one of the many unique properties which distinguish malignant from benign tumor cells. This is the first report documenting the chemotactic responsiveness of non-ascites tumors and fibrosarcomas.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7468766      PMCID: PMC1903675     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Electron microscopic observations on formation of pulmonary metastases.

Authors:  W F Sindelar; T S Tralka; A S Ketcham
Journal:  J Surg Res       Date:  1975-02       Impact factor: 2.192

2.  A unique complement derived chemotactic factor for tumor cells.

Authors:  A G Romualdez; P A Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

3.  Invasion of liver tissue by blood-borne mammary carcinoma cells.

Authors:  K P Dingemans
Journal:  J Natl Cancer Inst       Date:  1974-12       Impact factor: 13.506

4.  Resorbing bone is chemotactic for monocytes.

Authors:  G R Mundy; J Varani; W Orr; M D Gondek; P A Ward
Journal:  Nature       Date:  1978-09-14       Impact factor: 49.962

5.  The selection and characterization of an invasive variant of the B16 melanoma.

Authors:  I R Hart
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

6.  A comparison of the migration patterns of normal and malignant cells in two assay systems.

Authors:  J Varani; W Orr; P A Ward
Journal:  Am J Pathol       Date:  1978-01       Impact factor: 4.307

7.  Nonimmune chemotaxis in vivo: inhibition by complement depletion with cobra factor.

Authors:  S Wiener; S Lendvai; B Rogers; M Urivetzky; E Meilman
Journal:  Am J Pathol       Date:  1973-12       Impact factor: 4.307

8.  Complement-derived leukotactic factors in inflammatory synovial fluids of humans.

Authors:  P A Ward; N J Zvaifler
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

9.  Comparison of cell attachment and caseinolytic activities of five tumour cell types.

Authors:  J Varani; W Orr; P A Ward
Journal:  J Cell Sci       Date:  1978-12       Impact factor: 5.285

10.  Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.

Authors:  E H Vallota; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

View more
  8 in total

1.  Differential expression of a lamininlike substance by high- and low-metastatic tumor cells.

Authors:  J Varani; E J Lovett; J P McCoy; S Shibata; D E Maddox; I J Goldstein; M Wicha
Journal:  Am J Pathol       Date:  1983-04       Impact factor: 4.307

2.  Laminin production by murine melanoma cells: possible involvement in cell motility.

Authors:  S E Fligiel; K A Laybourn; B P Peters; R W Ruddon; J C Hiserodt; J Varani
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

3.  Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro.

Authors:  J B McCarthy; L T Furcht
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

4.  Platelet factors induce chemotactic migration of murine mammary adenocarcinoma cells with different metastatic capabilities.

Authors:  M A Sarach; R A Rovasio; A R Eynard
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

Review 5.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

6.  Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.

Authors:  F W Orr; E J Delikatny; S Mokashi; G V Krepart; H G Stiver
Journal:  Am J Pathol       Date:  1983-01       Impact factor: 4.307

7.  Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis.

Authors:  W J Manishen; K Sivananthan; F W Orr
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

8.  Chemotaxis of metastatic tumor cells.

Authors:  J Varani
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.